[1] Alani RM, Munger K. Human papillomavirus and associated malignancies[J]. J Clin Oncol, 1998, 16(1): 330-7. [2] 郑燕芳,张积仁,屈良鹄,等.两种抗HPV核酶的设计、表达与活性鉴定[J].中华实验与临床病毒学杂志,1999,13(2):238,242.Zheng YF, Zhang JR, Qu LH, et al. The design, expression and activity evaluation of two kinds ofanti-HPV ribozyme [J]. Chin J Exp Clin Virol, 13(2): 238,242. [3] 郑燕芳,饶智国,张积仁.特异性核酶对宫颈癌细胞系Caski增殖与凋亡的影响[J].第一军医大学学报,2002,22(6):496-502.Zheng YF, Rao ZG, Zhang JR. Effects of anti-HPV16 E6-ribozymeon the proliferation and apoptosis of human cervical cancer cell line Caski [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2002, 22(6): 496-502. [4] Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells [J]. Cancer Res,1987, 47(12): 3239-45. [5] Chen Z, Kamath P, Zhang S, et al. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavius type 18[J].Cancer Gene Therapy, 1996, 3(1): 18-23. [6] Zheng YF,Zhang JR,Qu LH,et al. Effectiveness ofa ribozyme for cleavage of an RNA transcript from human papillomavirus type 16[J]. Int J Modern Cancer Ther, 1998, 1(1): 134-8. [7] 郑燕芳,饶智国,张积仁.抗HPV16E6核酶对宫颈癌细胞恶性表型的影响[J].中国肿瘤生物治疗杂志,2002,9(3):183-5.Zheng YF, Rao ZG, Zhang JR. The effect of anti-HPV16 E6- ribozyme on malignant phenotypes of cervical carcinoma cell line[J]. Chin J Cancer Biother, 2002, 9(3): 183-5. [8] Tokumo K, Kodama J, Seki N, et al. Different angiogenic pathways in human cervical cancers [J]. Gynecol Oncol, 1998,68(1): 38-44. [9] Santin AD, Hermonat PL, Ravaggi A, et al. Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix [J]. Obstet Gynecol, 1999, 94(1):78-82. [10] Ueda M, Terai Y, Yamashita Y, et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas[J]. Int J Cancer, 2002, 98(3): 335-43. [11] Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2[J]. Cell, 1995, 83(3): 493-501. [12] Jaime LM, Kathleen ML, Mane TK, et al. Antiangiogentic and antitumor of cyclooxygenas-2 inhhibitors [J]. Cancer Res, 2000, 60:1306-11. [13] 饶智国,张积仁,郑燕芳,等.抗HPV16E6核酶对宫颈癌Caski细胞化疗的影响[J].第一军医大学学报,2002,22(4):316-9Rao ZG, Zhang JR, Zheng YF, et al. Effect of anti-HPV16 E6-ribozyme on the sensitivity of cervical carcinoma cell line to chemotherapy[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(4): 316-9. |